References
- Veyrat-Follet PC, Farinotti R, Palmer JL. Physiology of chemotherapy-induced emesis and antiemetic therapy. Drugs 1997; 53: 206–234.
- Bountra C, Gale JD, Gardner CJ, et al. Towards understand-ing the aetiology and pathophysiology of the emetic reflex: novel approaches to antiemetic drugs. Oncology 1996; 53 Suppl 1: 102–9.
- Hesketh PJ, Gandara DR. Serotonin antagonists: a new class of antiemetic agents. J Natl Cancer Inst 1991; 83: 613–20.
- Gregory RE, Ettinger DS. Percentage HT3 receptor antago-nists for the prevention of chemotherapy-induced nausea and vomiting. Drugs 1998; 55: 173–89.
- Wilde MI, Markham A. Ondansetron. A review of its phar-macology and preliminary clinical findings in novel applica-tions. Drugs 1996; 52: 773–94.
- Italian Group For Antiemetic Research. Ondansetron dex-amethasone vs. metoclopramide dexamethasone diphen-hydramine in prevention of cisplatin-induced emesis. Lancet 1992; 340: 96–9.
- Priestman TJ, Roberts JT, Lucraft H, et al. Results of ran-domized, double-blind, comparative study of ondansetron and metoclopramide in the prevention of nausea and vomit-ing following high-dose upper abdominal irradiation. Clin Oncol 1990; 2: 71–5.
- Mitchelson F. Pharmacological agents affecting emesis. A review (Part II). Drugs 1992; 43: 443–63.
- Orjales A, Mosquera R, Labeaga L, Rodes R. New 2-piper-azinylbenzimidazole derivatives as 5-HT3 antagonists: synthe-sis and pharmacological evaluation. J Med Chem 1997; 40: 586–93.
- Dorval ED, Mueller GP, Eng RR, Durakovic A, Conklin JJ, Dubois A. Effect of ionizing radiation on gastric secretion and gastric motility in monkeys. Gastroenterology 1985; 89: 374–80.
- Cooper JR, Mattson JL. Control of radiation-induced emesis with promethazine, cimetidine, thiethylperazine, or naloxone. Am J Vet Res 1979; 40: 1057–61.
- Dixon WJ, Massey FJ. Introduction to statistical analysis. New York: McGraw Hill, 1964: 380–94.
- Stott JR, Barnes GR, Wright RJ, Ruddock CJ. The effect on motion sickness and oculomotor function of GR 38032F, a 5-HT3-receptor antagonist with anti-emetic properties. Br J Clin Pharmacol 1989; 27: 147–57.
- Harding RK. Prodromal effects of radiation: pathways, mod-els, and protection by antiemetics. Pharmac Ther 1988; 39: 335–45.
- Naylor RJ, Rudd JA. Mechanisms of chemotherapy/radio-therapy-induced emesis in animal models. Oncology 1996; 53 Suppl 1: 8–17.
- Mattson JL, Crdts RE, Yochmowitz MG, Hardy KA. Pre-vention of radiation emesis in dogs by combination of drugs. Int J Radiat Oncol Biol Phys 1984; 10: 1067–72.
- Langham WH, Brooks PM, Grahn D. Radiation biology and space environmental parameters in manned spacecraft design and operations. Aerospace Med 1965; 36 (2, Suppl 2): 14–55.